Digestive & Intestinal Remedies (Pharmacies) - Estonia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$15.72m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.88%, resulting in a market volume of US$19.95m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$11.92 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Estonia has been experiencing steady growth in recent years.

Customer preferences: Customers in Estonia have shown a growing interest in digestive and intestinal remedies. This can be attributed to the increasing awareness about digestive health and the importance of maintaining a healthy gut. Consumers are becoming more conscious of their diet and lifestyle choices, leading to a higher demand for products that can alleviate digestive issues such as indigestion, bloating, and constipation. Additionally, the aging population in Estonia has also contributed to the growth of this market, as older individuals are more prone to digestive problems and seek remedies to alleviate their symptoms.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Estonia is the rising popularity of natural and herbal remedies. Consumers are increasingly seeking products that are made from natural ingredients and have fewer side effects. This trend is in line with the global shift towards more holistic and natural approaches to healthcare. As a result, there has been a surge in the demand for herbal teas, probiotics, and dietary supplements that promote digestive health. Another trend in the market is the increasing availability of digestive remedies in pharmacies. Pharmacies in Estonia have expanded their product offerings to cater to the growing demand for digestive and intestinal remedies. This has made it more convenient for consumers to access these products, as they can now purchase them alongside their regular medications. Pharmacies also provide a trusted source of information and advice, which is particularly important for consumers seeking remedies for their digestive issues.

Local special circumstances: Estonia has a well-developed healthcare system with a strong emphasis on preventive care. This has created a favorable environment for the growth of the Digestive & Intestinal Remedies market. The government has implemented various initiatives to promote healthy lifestyles and raise awareness about the importance of digestive health. This has further contributed to the demand for digestive remedies, as consumers are actively seeking ways to improve their digestive well-being.

Underlying macroeconomic factors: The growing economy of Estonia has also played a role in the development of the Digestive & Intestinal Remedies market. As disposable incomes increase, consumers are more willing to spend on healthcare products and remedies. The rising middle class in Estonia has become more health-conscious and is willing to invest in products that can improve their quality of life. This has created a favorable market for digestive remedies, as consumers are willing to pay for effective solutions to their digestive issues. In conclusion, the Digestive & Intestinal Remedies market in Estonia is experiencing growth due to increasing customer preferences for natural and herbal remedies, the availability of products in pharmacies, local special circumstances promoting digestive health, and the underlying macroeconomic factors of a growing economy and rising disposable incomes.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.